[e-farmacos] NPS RADAR Enero 2008

["Madurga, Mariano" <mmadurga@agemed.es>]

Estimadas y estimados,

La NPS (National Prescribing Service, de Australia) acaba de publicar su edicion del RADAR de enero 2008. 

Temas:

Varenicline (Champix) for smoking cessation <http://correoweb.msc.es/exchweb/bin/redir.asp?URL=http://radar.optin.com.au/a?16844032-1189100.019.009%26page=1%26content=/npsradar/content/varenicline.html>  

New product PBS listed January 2008 
Varenicline is a new non-nicotine drug that may assist smokers in quitting. It must be prescribed as part of a comprehensive smoking cessation program. The PBS will only subsidise one course of varenicline per patient per year. 

More <http://correoweb.msc.es/exchweb/bin/redir.asp?URL=http://radar.optin.com.au/a?16844032-1189100.019.00a%26page=1%26content=/npsradar/content/varenicline.html> 

Medicine Updates on alendronate, fluticasone with salmeterol, and varenicline <http://correoweb.msc.es/exchweb/bin/redir.asp?URL=http://radar.optin.com.au/a?16844032-1189100.019.00b%26page=2%26content=/resources/content/MedicineUpdate_home.html>  

Consumer versions of NPS RADAR

New Medicine Updates discuss 

* Alendronate (Alendro Once Weekly, Fosamax Once Weekly, Fosamax Plus) for osteoporosis in people at high risk of fracture 
* Fluticasone with salmeterol (Seretide) for chronic obstructive pulmonary disease 
* Varenicline (Champix) for smoking cessation. 

Medicine Update helps consumers to ask the right questions about new medicines, and helps them compare the potential benefits and harms of a new medicine with other medicines.

Disponible en: 

http://www.npsradar.org.au/site.php?page=1&content=/npsradar/content/januaryemail.html

Mariano Madurga
AEMPS
mmadurga@agemed.es